Last reviewed · How we verify

NCT04614701

Correlation of Carotid Flow Time and Cardiac Output.

Withdrawn Last updated 27 June 2022
What this trial tests

trial testing Carotid Artery Ultrasound Measure in Volume Responsiveness. Withdrawn.

Timeline
1 September 2022
Primary endpoint
31 December 2022
31 March 2023

Quick facts

Lead sponsorSt. Boniface Hospital
StatusWithdrawn
Study typeOBSERVATIONAL
Start date1 September 2022
Primary completion31 December 2022
Estimated completion31 March 2023
Sites1 location across Canada

Drugs / interventions tested

Conditions studied

Sponsor

St. Boniface Hospital

Who can join

Adults 18 to 80, any sex, with Volume Responsiveness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Assessment of common carotid artery flow is more easily done and can be taught more broadly than transthoracic echocardiography, providing a greater number of clinicians a tool to assess volume responsiveness. These assessments are of great importance to patients with COVID-19, who often present with hypotension requiring fluids, which must be balanced against limiting fluid administration to minimize pulmonary edema.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other St. Boniface Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04614701.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing